US2020397904A1PendingUtilityA1
Formulations of rifaximin and uses thereof
Est. expiryJul 12, 2030(~4 yrs left)· nominal 20-yr term from priority
A61P 31/04A61K 9/2027C07D 498/22A61K 47/38A61K 9/4866A61K 31/437A61K 47/32A61K 9/2054A61P 1/00A61K 9/1641A61K 9/1652A61K 9/146A61K 9/10A61K 9/4858A61P 31/00
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to new rifaximin forms comprising solid dispersions of rifaximin, methods of making same and to their use in medicinal preparations and therapeutic methods.
Claims
exact text as granted — not AI-modified1 - 12 . (canceled)
13 . A method of treating a bowel related disorder in a subject in need thereof, comprising administering to the subject a solid dispersion comprising rifaximin and a polymer, wherein the polymer comprises from about 10% to about 60% by weight of the solid dispersion and is selected from the group consisting of polyvinylpyrrolidone (PVP) grade K-90, hydroxypropylmethyl cellulose phthalate (HPMC-P) grade 55, hydroxypropyl methylcellulose acetate succinate (HPMC-AS) grades HG and MG, and polymethacrylate, and wherein said solid dispersion comprises a non-crystalline fully miscible dispersion comprising said rifaximin and said polymer.
14 . The method of claim 13 , wherein the bowel related disorder is irritable bowel syndrome.
15 . The method of claim 13 , wherein the bowel related disorder is hepatic encephalopathy.
16 . The solid dispersion of claim 13 , wherein said rifaximin and said polymer are present in equal amounts, and each of said rifaximin and said polymer comprises from about 10% to about 50% by weight of said solid dispersion.
17 . The solid dispersion of claim 14 , wherein said rifaximin and said polymer are present in equal amounts, and each of said rifaximin and said polymer comprises from about 10% to about 50% by weight of said solid dispersion.
18 . The solid dispersion of claim 15 , wherein said rifaximin and said polymer are present in equal amounts, and each of said rifaximin and said polymer comprises from about 10% to about 50% by weight of said solid dispersion.
19 . The solid dispersion of claim 13 , wherein said polymer comprises HPMC-AS grade MG or HPMC-AS grade HG.
20 . The solid dispersion of claim 14 , wherein said polymer comprises HPMC-AS grade MG or HPMC-AS grade HG.
21 . The solid dispersion of claim 15 , wherein said polymer comprises HPMC-AS grade MG or HPMC-AS grade HG.
22 . The solid dispersion of claim 16 , wherein said polymer comprises HPMC-AS grade MG or HPMC-AS grade HG.
23 . The solid dispersion of claim 17 , wherein said polymer comprises HPMC-AS grade MG or HPMC-AS grade HG.
24 . The solid dispersion of claim 18 , wherein said polymer comprises HPMC-AS grade MG or HPMC-AS grade HG.
25 . The solid dispersion of claim 13 , wherein said non-crystalline fully miscible dispersion further comprises a non-ionic surfactant.
26 . The solid dispersion of claim 14 , wherein said non-crystalline fully miscible dispersion further comprises a non-ionic surfactant.
27 . The solid dispersion of claim 15 , wherein said non-crystalline fully miscible dispersion further comprises a non-ionic surfactant.
28 . The solid dispersion of claim 16 , wherein said non-crystalline fully miscible dispersion further comprises a non-ionic surfactant.
29 . The solid dispersion of claim 19 , wherein said non-crystalline fully miscible dispersion further comprises a non-ionic surfactant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.